The recent application of 3D-QSAR and docking studies to novel HIV-protease inhibitor drug discovery.

Expert Opinion on Drug Discovery
Fisayo A OlotuMahmoud E S Soliman

Abstract

Despite the availability of FDA approved inhibitors of HIV protease, numerous efforts are still ongoing to achieve 'near-perfect' drugs devoid of characteristic adverse side effects, toxicities, and mutational resistance. While experimental methods have been plagued with huge consumption of time and resources, there has been an incessant shift towards the use of computational simulations in HIV protease inhibitor drug discovery. Herein, the authors review the numerous applications of 3D-QSAR modeling methods over recent years relative to the design of new HIV protease inhibitors from a series of experimentally derived compounds. Also, the augmentative contributions of molecular docking are discussed. Efforts to optimize 3D QSAR and molecular docking for HIV-1 drug discovery are ongoing, which could further incorporate inhibitor motions at the active site using molecular dynamics parameters. Also, highly predictive machine learning algorithms such as random forest, K-means, decision trees, linear regression, hierarchical clustering, and Bayesian classifiers could be employed.

References

Jul 7, 1995·Journal of Medicinal Chemistry·A R OrtizR C Wade
Aug 5, 1994·Journal of Medicinal Chemistry·D E Walters, R M Hinds
May 24, 1996·Journal of Medicinal Chemistry·B D Silverman, D E Platt
Mar 1, 1997·Journal of Computer-aided Molecular Design·A M FergusonP J Snaith
Mar 3, 1999·Journal of Medicinal Chemistry·D D RobinsonW G Richards
Jun 22, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B Max, R Sherer
Dec 10, 2002·Current Topics in Medicinal Chemistry·Miki Akamatsu
Jun 27, 2003·Journal of Computer-aided Molecular Design·Wolfgang Sippl
Jul 29, 2003·AIDS Research and Human Retroviruses·Daniel González de RequenaVincent Soriano
Dec 2, 2005·Scandinavian Journal of Clinical and Laboratory Investigation·K V MikkelsenT Haghfelt
Feb 9, 2006·The Journal of Antimicrobial Chemotherapy·Berta RodésVincent Soriano
Jul 14, 2007·Current Medicinal Chemistry·Gerald H LushingtonJenna L Wang
Nov 6, 2007·Bioorganic & Medicinal Chemistry Letters·Serdar DurdagiThomas Mavromoustakos
Jan 26, 2008·Journal of Computer-aided Molecular Design·Jitender VermaEvans C Coutinho
Apr 22, 2008·AIDS Patient Care and STDs·Rose Kim, John D Baxter
Apr 30, 2008·Archiv der Pharmazie·Patcharawee NunthanavanitJiraporn Ungwitayatorn
Oct 28, 2008·Bioorganic & Medicinal Chemistry Letters·Serdar DurdagiManthos G Papadopoulos
Dec 3, 2008·Journal of Molecular Modeling·Devendra K DhakedEvans C Coutinho
Feb 6, 2009·Journal of Medicinal Chemistry·Robert N JorissenMichael K Gilson
Feb 12, 2009·Therapeutics and Clinical Risk Management·Ashish Chandwani, Jonathan Shuter
Jul 21, 2009·European Journal of Medicinal Chemistry·Elaine Fontes Ferreira da CunhaMagaly Girão Albuquerque
Oct 27, 2009·Antiviral Research·Annemarie M J WensingMonique Nijhuis
Nov 26, 2009·Current Topics in Medicinal Chemistry·Jitender VermaEvans C Coutinho
Jan 14, 2010·Journal of Molecular Modeling·Vijay M KhedkarEvans C Coutinho
Jul 28, 2010·Antimicrobial Agents and Chemotherapy·Soo-Yon RheeRobert W Shafer
Aug 28, 2010·International Review of Cell and Molecular Biology·Johanna Weiss, Walter Emil Haefeli
Jan 13, 2011·Medicinal Chemistry·Leonardo G FerreiraAdriano D Andricopulo
Mar 16, 2011·Antimicrobial Agents and Chemotherapy·Soren GanttJeffrey Vieira
Jul 1, 2010·Viruses·François Clavel, Fabrizio Mammano
Aug 1, 1988·Journal of the American Chemical Society·R D CramerJ D Bunce
Jan 13, 2012·Protein Science : a Publication of the Protein Society·Yunfeng TieIrene T Weber
May 21, 2013·Chemistry Central Journal·Zaheer Ul-HaqSobia Ahsan Halim
Feb 12, 2014·International Journal of STD & AIDS·F V CresswellD Richardson
Dec 30, 2014·Trends in Pharmacological Sciences·Yu-Chian Chen
Apr 22, 2015·HIV/AIDS : Research and Palliative Care·Zhengtong LvYong Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.